Russia’s sovereign wealth fund RDIF said early results from its phase three clinical trial of Russia’s coronavirus vaccine, called “Sputnik V,” showed its efficacy amounted to 92%
https://www.cnbc.com/2020/11/11/cor...-says-its-vaccine-is-92percent-effective.html
https://www.cnbc.com/2020/11/11/cor...-says-its-vaccine-is-92percent-effective.html


